Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,533 | 146 | 89.5% |
| Education | $413.01 | 7 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $684.58 | 31 | $0 (2024) |
| Janssen Biotech, Inc. | $596.51 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $453.62 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $322.29 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $283.40 | 17 | $0 (2024) |
| GENZYME CORPORATION | $251.81 | 11 | $0 (2024) |
| Lilly USA, LLC | $237.06 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $188.07 | 8 | $0 (2024) |
| Incyte Corporation | $179.26 | 9 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $130.81 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,651 | 71 | ABBVIE INC. ($342.87) |
| 2023 | $941.89 | 35 | E.R. Squibb & Sons, L.L.C. ($208.87) |
| 2022 | $800.20 | 25 | ABBVIE INC. ($200.73) |
| 2021 | $552.11 | 22 | Janssen Biotech, Inc. ($138.48) |
All Payment Transactions
153 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.66 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $27.04 | General |
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Immunology | ||||||
| 10/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Immunology | ||||||
| 10/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $6.70 | General |
| 09/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Immunology | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.45 | General |
| Category: Immunology | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: IMMUNOLOGY | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Immunology | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Dermatology | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Dermatology | ||||||
| 08/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: DERMATOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,545 | 2,698 | $258,057 | $79,554 |
| 2022 | 12 | 815 | 1,228 | $155,293 | $41,239 |
| 2021 | 7 | 284 | 444 | $88,543 | $15,502 |
| 2020 | 8 | 295 | 498 | $94,868 | $14,608 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 300 | 353 | $55,385 | $17,505 | 31.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 170 | 201 | $39,103 | $12,646 | 32.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 133 | $29,533 | $9,603 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 248 | 306 | $35,466 | $9,065 | 25.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 138 | 146 | $25,450 | $7,246 | 28.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 185 | 1,093 | $12,321 | $4,348 | 35.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 128 | 162 | $9,561 | $4,206 | 44.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 73 | 73 | $14,323 | $3,629 | 25.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 35 | $10,228 | $3,223 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $9,025 | $2,523 | 28.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 63 | 66 | $6,456 | $1,912 | 29.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $4,961 | $1,637 | 33.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 29 | 39 | $3,382 | $1,222 | 36.1% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $2,798 | $762.59 | 27.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 11 | 33 | $63.94 | $24.49 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 140 | $23,949 | $7,176 | 30.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 72 | 79 | $16,693 | $5,513 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 86 | 86 | $18,616 | $4,935 | 26.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 93 | 96 | $20,135 | $4,810 | 23.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 135 | 152 | $27,540 | $4,600 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 47 | 55 | $13,253 | $3,948 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $8,187 | $2,402 | 29.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 60 | 74 | $4,295 | $1,903 | 44.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 96 | 434 | $10,612 | $1,788 | 16.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 45 | 48 | $5,241 | $1,765 | 33.7% |
About Cameron Bader, PA-C
Cameron Bader, PA-C is a Physician Assistant healthcare provider based in Niceville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2018. The National Provider Identifier (NPI) number assigned to this provider is 1679058986.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cameron Bader, PA-C has received a total of $3,946 in payments from pharmaceutical and medical device companies, with $1,651 received in 2024. These payments were reported across 153 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,533).
As a Medicare-enrolled provider, Bader has provided services to 2,939 Medicare beneficiaries, totaling 4,868 services with total Medicare billing of $150,903. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Niceville, FL
- Active Since 10/02/2018
- Last Updated 03/27/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679058986
Products in Payments
- TREMFYA (Drug) $523.89
- DUPIXENT (Biological) $516.59
- SKYRIZI (Biological) $405.32
- Sotyktu (Drug) $331.33
- RINVOQ (Biological) $279.26
- TALTZ (Drug) $198.44
- OPZELURA (Drug) $179.26
- COSENTYX (Drug) $140.60
- AUSTEDO (Drug) $130.81
- ILUMYA (Biological) $122.99
- AFREZZA (Drug) $109.14
- COSENTYX (Biological) $109.06
- EUCRISA (Drug) $94.27
- REMICADE (Biological) $72.62
- LIBTAYO (Biological) $57.51
- Cimzia (Drug) $51.43
- Rybelsus (Drug) $50.80
- Otezla (Drug) $44.17
- ADBRY (Biological) $41.05
- EBGLYSS (Drug) $38.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Niceville
Mrs. Rachel Reid, Pa-C, PA-C
Physician Assistant — Payments: $5,946
James Smith, P.a, P.A
Physician Assistant — Payments: $2,136
Molly Nixon, Pa, PA
Physician Assistant — Payments: $1,653
Allison Herman, Pa-C, PA-C
Physician Assistant — Payments: $823.06
Leah Tedder
Physician Assistant — Payments: $642.00
Amanda Outly, Pa, PA
Physician Assistant — Payments: $374.79